These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30777977)

  • 21. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Efficiency of Intravitreal Dexamethasone Implants in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion.
    Unsal E; Eltutar K; Sultan P; Gungel H
    J Ocul Pharmacol Ther; 2015; 31(6):350-6. PubMed ID: 26133058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute endophthalmitis after 25-gauge sutureless vitrectomy.
    Acar N; Unver YB; Altan T; Kapran Z
    Int Ophthalmol; 2007 Dec; 27(6):361-3. PubMed ID: 17492400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).
    Capone A; Singer MA; Dodwell DG; Dreyer RF; Oh KT; Roth DB; Walt JG; Scott LC; Hollander DA
    Retina; 2014 Feb; 34(2):342-51. PubMed ID: 23846381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion.
    Di Antonio L; Toto L; Carpineto P; Mastropasqua A; De Nicola C; Mastropasqua L
    Eur J Ophthalmol; 2014; 24(1):134-7. PubMed ID: 23709332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.
    Korobelnik JF; Kodjikian L; Delcourt C; Gualino V; Leaback R; Pinchinat S; Velard ME
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2307-2318. PubMed ID: 27286894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
    Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
    Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.
    Tabatabaii A; Ahmadraji A; Khodabande A; Mansouri M
    Middle East Afr J Ophthalmol; 2013; 20(1):87-8. PubMed ID: 23580860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Dexamethasone Intravitreal Implant for Treatment of Refractory Macular Edema Secondary to Retinal Vein Occlusion in Taiwan.
    Sheu SJ; Wu TT; Horng YH
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):461-7. PubMed ID: 26067779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-Term Assessment of Intravitreal Dexamethasone Implant Using Enhanced-Depth Image Optical Coherence Tomography and Optical Coherence Tomography Angiography in Patients with Retinal Vascular Diseases.
    Minnella AM; Federici M; Pagliei V; Lanza A; Gambini G; Caputo CG; Falsini B; Caporossi A
    Adv Ther; 2019 Feb; 36(2):416-425. PubMed ID: 30565180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus Induced Endogenous Endophthalmitis with Pink Hypopyon.
    Ranjan P; Joshi P; Gupta M
    Ocul Immunol Inflamm; 2018; 26(4):504-505. PubMed ID: 27937098
    [No Abstract]   [Full Text] [Related]  

  • 32. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion.
    Abdolrahimzadeh S; Plateroti P; Scarinci F; Plateroti AM
    Acta Ophthalmol; 2016 Dec; 94(8):e810-e811. PubMed ID: 27125991
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison between "early" or "late" intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up.
    Pacella F; La Torre G; Basili S; Autolitano M; Pascarella A; Lenzi T; Pacella E
    Cutan Ocul Toxicol; 2017 Sep; 36(3):224-230. PubMed ID: 27903073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema.
    Turaka K; Kwong HM; De Souza S
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):196-7. PubMed ID: 23402344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.
    Meyer LM; Schönfeld CL
    J Ocul Pharmacol Ther; 2013; 29(6):560-5. PubMed ID: 23480270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
    Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
    Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracrystalline Ozurdex
    Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
    Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
    Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
    Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
    Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.